2011
DOI: 10.1016/j.jaci.2010.09.027
|View full text |Cite
|
Sign up to set email alerts
|

Ara h 2 peptides containing dominant CD4+ T-cell epitopes: Candidates for a peanut allergy therapeutic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
91
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 84 publications
(100 citation statements)
references
References 62 publications
3
91
0
Order By: Relevance
“…T-cell epitope peptides from major allergens could provide effective and safer (non-IgE-reactive) alternatives for the conventional immunotherapy treatment [44]. Five dominant CD4+ T-cell epitopes of Ara h 2 peptides have been identified as novel candidates for T-cell-targeted peanut allergy therapeutics [47].…”
Section: Discussionmentioning
confidence: 99%
“…T-cell epitope peptides from major allergens could provide effective and safer (non-IgE-reactive) alternatives for the conventional immunotherapy treatment [44]. Five dominant CD4+ T-cell epitopes of Ara h 2 peptides have been identified as novel candidates for T-cell-targeted peanut allergy therapeutics [47].…”
Section: Discussionmentioning
confidence: 99%
“…Peptides derived from enzymatically hydrolyzed flours selected for OIT should ideally contain the epitopes targeting CD4+ T cells, but lack the capacity to cross-link IgE on mast cells and basophils. For example, the potential for Ara h 2 peptides to be used in OIT was investigated in model systems [12]. The researchers identified short Ara h 2 peptides containing T cell epitopes that target Ara h 2-specific CD4+ T cells but lack the capacity to bind IgE, which suggest these peptides are good immunotherapy candidates [12].…”
Section: Introductionmentioning
confidence: 99%
“…For example, the potential for Ara h 2 peptides to be used in OIT was investigated in model systems [12]. The researchers identified short Ara h 2 peptides containing T cell epitopes that target Ara h 2-specific CD4+ T cells but lack the capacity to bind IgE, which suggest these peptides are good immunotherapy candidates [12]. Before enzymatically hydrolyzed flours can be considered for OIT, additional basic characterization data is needed.…”
Section: Introductionmentioning
confidence: 99%
“…Nitrocellulose membrane (0.2 µm pore size) was dotted with 10 µg of Pas n 1 protein or 20 µg of Pas n 1 peptide, blocked with TRIS-buffered saline containing 0.05% Tween 20 and 5% sucrose, incubated with individual subject sera (diluted 1:10) and IgE binding was assessed as described [24]. …”
Section: Methodsmentioning
confidence: 99%